The survival rate of patients with advanced oesophageal cancer is very low and can vary significantly, even among patients with the same TNM stage. It is important to look for indicators that are economical and readily available to predict overall survival. | Predictive value of lymphocyte-to-monocyte ratio LMR and neutrophil-to-lymphocyte ratio NLR in patients with oesophageal cancer undergoing concurrent chemoradiotherapy